1. Home
  2. Live Updates
  3. Theravance biopharma inc

Live Breaking News & Updates on Theravance biopharma inc

Stay informed with the latest breaking news from Theravance biopharma inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Theravance biopharma inc and stay connected to the pulse of your community

BTIG Starts Theravance Biopharma With Buy Rating, $21 Price Target

--
Price: 9.52, Change: +0.59, Percent Change: +6.61
...

Theravance-biopharma-inc , Theravance-biopharma ,

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024

DUBLIN, April 10, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. today announced it will host a virtual KOL event on Thursday, May 23, 2024 from 10:00 AM to 11:30 AM ET, featuring Horacio...

Dublin , Ireland , United-states , America , Theravance-biopharma , Rhonda-farnum , Italo-biaggioni , Horacio-kaufmann , Feliciab-axelrod , Rick-winningham , Theravance-biopharma-inc , Dysautonomia-center

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript

Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.04.

China , London , City-of , United-kingdom , United-states , Japan , Rick-winningham , Douglas-tsao , Theravance-biopharma , David-risinger , Rhonda-farnum , Aziz-sawaf

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Dublin , Ireland , Ricke-winningham , Theravance-biopharma , Prnewswire-theravance-biopharma-inc , Company-annual-report-on-form , Mylan-ireland , Development-rd-expenses , International-symposium , Neurological-institute , Securities-exchange

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

/PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced financial and operational results for the...

United-states , Dublin , Ireland , Theravance-biopharma , Ricke-winningham , Company-form , While-viatris-inc , Theravance-biopharma-inc , Us-department-of-justice , Teva-pharmaceuticals-inc , Teva-pharmaceuticals-united-states-inc , International-symposium

Theravance Bio: Q4 Earnings Snapshot -February 26, 2024 at 04:40 pm EST

GEORGE TOWN, Cayman Islands — GEORGE TOWN, Cayman Islands — Theravance Biopharma Inc. on Monday reported a loss of $8.5 million in its fourth quarter.
On a per-share basis, the George...

Cayman-islands , Cayman , 00 , Theravance-biopharma-inc , Zacks-investment-research , Cayman-islands-based , Investment-research , Automated-insights , Markets ,

Theravance Biopharma to Participate in an Upcoming Investor Conference

DUBLIN, Feb. 22, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. will participate in the CNS Corporate Panel Discussion at the TD Cowen 44th Annual Health Care Conference in Boston, MA on Tuesday,...

Dublin , Ireland , Boston , Massachusetts , United-states , Theravance-biopharma , Nasdaq , Theravance-biopharma-inc , Health-care-conference , Corporate-panel-discussion , Panel-discussion , Annual-health-care-conference

Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Logitech International (NASDAQ:LOGI)

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 20 points on Tuesday.

Sagimet-biosciences , Coinbase-global-inc , Bitfarms-ltd , Arcturus-therapeutics-holdings-inc , Logitech-international , Marathon-digital-holdings-inc , Cleanspark-inc , Sagimet-biosciences-inc , Theravance-biopharma-inc , Digital-holdings ,

Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dublin , Ireland , Spiriva-handihaler , Theravance-biopharma , Ricke-winningham , Theravance-biopharma-viatris , Company-form , Securities-exchange , Nasdaq , Prnewswire-theravance-biopharma-inc , Viatris-inc , Theravance-biopharma-inc

Theravance Biopharma's stock slides 21% after Phase 4 trial of COPD treatment fails to meet main goal

Theravance Biopharma Inc.’s stock tumbled 21% early Friday,ter the biotech said a Phase 4 trial of its Yupelri treatment for patients with severe to very...

Spiriva-handihaler , Theravance-biopharma-inc , Theravance-biopharma , Chronic-obstructive-pulmonary-disease , Article-normal , Biotechnology , Regulation-government-policy , Corporate-industrial-news , Theravance-biopharma-inc- , Tbph , Spx , S-amp-ampp-500-index